These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 9198888)

  • 1. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M; Schlaepfer J; Kappenberger L; Fromer M
    Schweiz Med Wochenschr; 1997 Apr; 127(15):623-30. PubMed ID: 9198888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Fananapazir L
    Circulation; 1992 Jan; 85(1 Suppl):I57-63. PubMed ID: 1728506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmia and hypertrophic cardiomyopathy.
    Shakespeare CF; Keeling PJ; Slade AK; McKenna WJ
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():31-6. PubMed ID: 1307192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy].
    Göktekin O; Ritsushi K; Matsumoto K; Hiroshi M
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):226-30. PubMed ID: 12223331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sudden death during Holter electrocardiographic monitoring in a patient with hypertrophic cardiomyopathy].
    Sato M; Takenaka K; Yamashita T; Koike S; Natori K; Nakahara K
    J Cardiol; 1998 May; 31(5):297-303. PubMed ID: 9617660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I
    Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiomyopathies. VIII. Sudden death in hypertrophic cardiomyopathy].
    Alfonso F
    Rev Esp Cardiol; 1996 Apr; 49(4):288-304. PubMed ID: 8650406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained arrhythmias in hypertrophic obstructive cardiomyopathy.
    Kowey PR; Eisenberg R; Engel TR
    N Engl J Med; 1984 Jun; 310(24):1566-9. PubMed ID: 6539421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sudden death and obstructive hypertrophic cardiomyopathy].
    Baille N
    Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):155-60. PubMed ID: 3890678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interventional treatment in hypertrophic cardiomyopathy].
    Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S
    Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory monitoring of the sudden death of an adolescent with hypertrophic cardiomyopathy.
    Gardin LL; Nanton MA; Hanna BD
    Can J Cardiol; 1994 Jun; 10(5):548-50. PubMed ID: 8012885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of cardiac arrhythmia in patients with hypertrophic cardiomyopathy].
    Wang Y; Cui YH; Wang DW
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):401-4. PubMed ID: 15061995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of invasive and noninvasive testing in risk stratification of sudden cardiac death in children and young adults: an electrophysiologic perspective.
    Attari M; Dhala A
    Pediatr Clin North Am; 2004 Oct; 51(5):1355-78. PubMed ID: 15331288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ
    J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.